96 related articles for article (PubMed ID: 11597187)
21. [Functional phage display of human interferon alpha lc/86D].
Ma X; Hu R; Lu H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Sep; 12(3):213-6. PubMed ID: 12526318
[TBL] [Abstract][Full Text] [Related]
22. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
[TBL] [Abstract][Full Text] [Related]
23. Interferon alpha2b is the predominant subvariant detected in human genomic DNAs.
Kaluz S; Kabát P; Gibadulinová A; Vojtassák J; Fuchsberger N; Kontsek P
Acta Virol; 1994 Apr; 38(2):101-4. PubMed ID: 7976860
[TBL] [Abstract][Full Text] [Related]
24. Amino acid substitutions in loop BC and helix C affect antigenic properties of helix D in hybrid IFN-alpha21a/alpha2c molecules.
Schmeisser H; Hu R; Kontsek P; Bekisz J; Zoon K
J Interferon Cytokine Res; 2002 Apr; 22(4):463-72. PubMed ID: 12034029
[TBL] [Abstract][Full Text] [Related]
25. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
Xu J; Liu S; Xu Y; Tien P; Gao G
Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
[TBL] [Abstract][Full Text] [Related]
26. Proteome characterization of human NK-92 cells identifies novel IFN-alpha and IL-15 target genes.
Rakkola R; Matikainen S; Nyman TA
J Proteome Res; 2005; 4(1):75-82. PubMed ID: 15707360
[TBL] [Abstract][Full Text] [Related]
27. Protein engineering of interferon alphas.
Hu R; Lei KJ; Bekisz J; Zoon KC
Methods Mol Med; 2005; 116():69-80. PubMed ID: 16000855
[TBL] [Abstract][Full Text] [Related]
28. Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype.
Namba K; Naka K; Dansako H; Nozaki A; Ikeda M; Shiratori Y; Shimotohno K; Kato N
Biochem Biophys Res Commun; 2004 Oct; 323(1):299-309. PubMed ID: 15351737
[TBL] [Abstract][Full Text] [Related]
29. Growth inhibitory effects of interferon-alpha subtypes vary according to human liver cancer cell lines.
Yano H; Yanai Y; Momosaki S; Ogasawara S; Akiba J; Kojiro S; Moriya F; Fukahori S; Kurimoto M; Kojiro M
J Gastroenterol Hepatol; 2006 Nov; 21(11):1720-5. PubMed ID: 16984596
[TBL] [Abstract][Full Text] [Related]
30. C2360, a nuclear protein expressed in human proliferative cytotrophoblasts, is a representative member of a novel protein family with a conserved coiled coil-helix-coiled coil-helix domain.
Westerman BA; Poutsma A; Steegers EA; Oudejans CB
Genomics; 2004 Jun; 83(6):1094-104. PubMed ID: 15177562
[TBL] [Abstract][Full Text] [Related]
31. Four novel ULBP splice variants are ligands for human NKG2D.
Cao W; Xi X; Wang Z; Dong L; Hao Z; Cui L; Ma C; He W
Int Immunol; 2008 Aug; 20(8):981-91. PubMed ID: 18544572
[TBL] [Abstract][Full Text] [Related]
32. Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the NK-cell promoting cytokine interleukin-12 in pre-eclampsia.
Bachmayer N; Rafik Hamad R; Liszka L; Bremme K; Sverremark-Ekström E
Am J Reprod Immunol; 2006; 56(5-6):292-301. PubMed ID: 17076673
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization of IRF3 and IRF7 in rainbow trout, Oncorhynchus mykiss: functional analysis and transcriptional modulation.
Holland JW; Bird S; Williamson B; Woudstra C; Mustafa A; Wang T; Zou J; Blaney SC; Collet B; Secombes CJ
Mol Immunol; 2008 Dec; 46(2):269-85. PubMed ID: 18805586
[TBL] [Abstract][Full Text] [Related]
34. Tumour necrosis factor-alpha impairs chorionic gonadotrophin beta-subunit expression and cell fusion of human villous cytotrophoblast.
Leisser C; Saleh L; Haider S; Husslein H; Sonderegger S; Knöfler M
Mol Hum Reprod; 2006 Oct; 12(10):601-9. PubMed ID: 16896069
[TBL] [Abstract][Full Text] [Related]
35. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
[TBL] [Abstract][Full Text] [Related]
36. Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C.
Mihm U; Grigorian N; Welsch C; Herrmann E; Kronenberger B; Teuber G; von Wagner M; Hofmann WP; Albrecht M; Lengauer T; Zeuzem S; Sarrazin C
Antivir Ther; 2006; 11(4):507-19. PubMed ID: 16856625
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the murine alpha interferon gene family.
van Pesch V; Lanaya H; Renauld JC; Michiels T
J Virol; 2004 Aug; 78(15):8219-28. PubMed ID: 15254193
[TBL] [Abstract][Full Text] [Related]
38. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
[TBL] [Abstract][Full Text] [Related]
39. Constitutive expression of tumor necrosis factor-alpha in cytotoxic cells of teleosts and its role in regulation of cell-mediated cytotoxicity.
Praveen K; Evans DL; Jaso-Friedmann L
Mol Immunol; 2006 Feb; 43(3):279-91. PubMed ID: 16199264
[TBL] [Abstract][Full Text] [Related]
40. Biological basis for a proper clinical application of alpha interferons.
Antonelli G
New Microbiol; 2008 Jul; 31(3):305-18. PubMed ID: 18843884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
